![Christopher Jon Matheny](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Jon Matheny
Plus aucun poste en cours
Profil
Christopher Jon Matheny worked as the Vice President-Development at Candel Therapeutics, Inc. from 2021 to 2023.
He holds a doctorate degree from The University of North Carolina at Chapel Hill.
Anciens postes connus de Christopher Jon Matheny
| Sociétés | Poste | Fin |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2023 |
Formation de Christopher Jon Matheny
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
